Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion type Assertion NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_head.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion description "[Despite the evidence of early insulin treatment lowering macrovascular (coronary artery disease, peripheral arterial disease and stroke) and microvascular (diabetic nephropathy, neuropathy and retinopathy) complications of T2DM, controversy exists among physicians on how to initiate and intensify insulin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_provenance.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion evidence source_evidence_literature NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_provenance.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion SIO_000772 23584214 NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_provenance.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion wasDerivedFrom befree-2016 NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_provenance.
- NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_assertion wasGeneratedBy ECO_0000203 NP1069080.RA4zG_-QmV3EJPOqxEpTRf-jTX-qRFWmYulu51dkFaWns130_provenance.